BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

988 related articles for article (PubMed ID: 19220062)

  • 1. Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD.
    Du J; Jiang H; Lin H
    Biochemistry; 2009 Apr; 48(13):2878-90. PubMed ID: 19220062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity.
    Frye RA
    Biochem Biophys Res Commun; 1999 Jun; 260(1):273-9. PubMed ID: 10381378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of NAD(+) in the deacetylase activity of the SIR2-like proteins.
    Landry J; Slama JT; Sternglanz R
    Biochem Biophys Res Commun; 2000 Nov; 278(3):685-90. PubMed ID: 11095969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
    Borra MT; Langer MR; Slama JT; Denu JM
    Biochemistry; 2004 Aug; 43(30):9877-87. PubMed ID: 15274642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous ADP-ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions.
    Bektaş M; Nurten R; Ergen K; Bermek E
    Cell Biochem Funct; 2006; 24(4):369-80. PubMed ID: 16142694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases.
    Zhao K; Harshaw R; Chai X; Marmorstein R
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8563-8. PubMed ID: 15150415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry.
    Sauve AA; Schramm VL
    Biochemistry; 2003 Aug; 42(31):9249-56. PubMed ID: 12899610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
    Parikh SL; Schramm VL
    Biochemistry; 2004 Feb; 43(5):1204-12. PubMed ID: 14756556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium falciparum Sir2: an unusual sirtuin with dual histone deacetylase and ADP-ribosyltransferase activity.
    Merrick CJ; Duraisingh MT
    Eukaryot Cell; 2007 Nov; 6(11):2081-91. PubMed ID: 17827348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oxidative stress on in vivo ADP-ribosylation of eukaryotic elongation factor 2.
    Bektaş M; Akçakaya H; Aroymak A; Nurten R; Bermek E
    Int J Biochem Cell Biol; 2005 Jan; 37(1):91-9. PubMed ID: 15381153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity and target proteins of arginine-specific mono-ADP-ribosylation in T-tubules of rabbit skeletal muscle.
    Klebl BM; Göpel SO; Pette D
    Arch Biochem Biophys; 1997 Nov; 347(2):155-62. PubMed ID: 9367520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIR2: the biochemical mechanism of NAD(+)-dependent protein deacetylation and ADP-ribosyl enzyme intermediates.
    Sauve AA; Schramm VL
    Curr Med Chem; 2004 Apr; 11(7):807-26. PubMed ID: 15078167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.
    Avalos JL; Bever KM; Wolberger C
    Mol Cell; 2005 Mar; 17(6):855-68. PubMed ID: 15780941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose.
    Tanner KG; Landry J; Sternglanz R; Denu JM
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14178-82. PubMed ID: 11106374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate binding and catalysis of ecto-ADP-ribosyltransferase 2.2 from rat.
    Ritter H; Koch-Nolte F; Marquez VE; Schulz GE
    Biochemistry; 2003 Sep; 42(34):10155-62. PubMed ID: 12939142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel components of NAD-utilizing metabolic pathways and prediction of their biochemical functions.
    de Souza RF; Aravind L
    Mol Biosyst; 2012 Jun; 8(6):1661-77. PubMed ID: 22399070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylation-dependent ADP-ribosylation by Trypanosoma brucei Sir2.
    Kowieski TM; Lee S; Denu JM
    J Biol Chem; 2008 Feb; 283(9):5317-26. PubMed ID: 18165239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coupling of histone deacetylation to NAD breakdown by the yeast silencing protein Sir2: Evidence for acetyl transfer from substrate to an NAD breakdown product.
    Tanny JC; Moazed D
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):415-20. PubMed ID: 11134535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of enzymatically active recombinant class III protein deacetylases.
    North BJ; Schwer B; Ahuja N; Marshall B; Verdin E
    Methods; 2005 Aug; 36(4):338-45. PubMed ID: 16091304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chromosomal SIR2 homologue with both histone NAD-dependent ADP-ribosyltransferase and deacetylase activities is involved in DNA repair in Trypanosoma brucei.
    García-Salcedo JA; Gijón P; Nolan DP; Tebabi P; Pays E
    EMBO J; 2003 Nov; 22(21):5851-62. PubMed ID: 14592982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.